Diagnostyka falls as Q4 operating costs, sales mix strain profit margins

Diagnostyka SA

21/04/2026 10:10

** Shares in Polish medical diagnostics company Diagnostyka DIAP.WA fall around 6.7% as higher operating expenses and a changing sales mix pressured its Q4 profit margins

** The company's Q4 core profit margin fell to 19.4% from 24.8% a year earlier, as operating costs rose 26% to 554 million zlotys. The full-year margin fell to 24.3% from 26.1 in 2024

** Q4 revenues rose over 22% year-on-year to 621 million zlotys  ($172.59 million), which Trigon analyst Katarzyna Kosiorek said beat the brokerage's estimates

** However, she noted that "the level of operating costs was about 18% higher than our assumptions, which had an impact on the significant reduction of the EBITDA margin"

** The brokerage expects a temporary negative stock price reaction, as a higher share of lower-margin business-to-business sales pointed to a normalisation after strong previous quarters, Kosiorek adds

** As of 0910 GMT, shares of the company were down 6.7%, on track for its worst day since its market debut February last year

($1 = 3.5982 zlotys)

 (Reporting by Rafal Nowak)

 ((RafalWojciech.Nowak@thomsonreuters.com; +48 58 769 66 63;))